Recent Quotes (30 days)

You have no recent quotes
chg | %

Solanbridge Group Inc  

(Public, OTCMKTS:SLNX)   Watch this stock  
Find more results for slnx
0.00000 (0.00%)
Oct 20 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.00 - 0.00
52 week 0.00 - 0.00
Open 0.00
Vol / Avg. 200,000.00/67,300.00
Mkt cap 249,430.00
P/E     -
Div/yield     -
EPS     -
Shares 2.49B
Beta     -
Inst. own 0%

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 25.06% -1.39%
Operating margin 25.06% -1.39%
EBITD margin - -1.39%
Return on average assets 160.81% -5.10%
Return on average equity - -
CDP Score - -


3431 Rayford Rd
SPRING, TX 77386-3649
United States - Map
+1-913-2222977 (Phone)
+1-832-2010892 (Fax)

Website links


Solanbridge Group, Inc. is a development-stage company. The Company is a holding company. The Company is looking to expand into the medical marijuana industry by developing a commercial grower's license in the Province of Nova Scotia, Canada and developing cannbidiol (CBD) infused products in Nevada, California and Colorado. The Company focuses on providing a product that will help physicians and patients in managing health, and it will be available only to Canadians holding a legal license to possess medical marijuana. Solanbridge Group Nova Scotia, Inc. is a subsidiary of the Company.

Officers and directors

Charles R. Shirley Chief Executive Officer, Director
Joseph Curci Director
Earle G. Hickey Director
Rosalia Miray Director
Luis Mora Director
Age: 43